/eh/2025-01-08/173633966714069467/picture.png)
/eh/2024-12-24/173503345348979036/Favorite-Icon.png){kind=icon}
/eh/2025-07-08/1751962110204480194/picture.png)
/eh/2025-06-21/1750485478958537574/countryInfoIcon.png)
/eh/2025-06-21/1750485741321434291/Hi-Sign-in-My-Nihao.png)
/eh/2025-06-21/1750485837193896318/cart.png)
/eh/2025-06-21/1750485968202533847/cart.png)
/eh/2025-04-17/1744862476612819675/hot-img.png)
/eh/2025-11-07/1762504524550532584/header-icon.jpg){kind=icon}
/eh/2025-07-07/1751875582852206790/header-icon.png){kind=icon}
/eh/2025-07-07/1751875587886277738/header-icon.png){kind=icon}
home
>
glutathione and triple negative breast cancer RK-251 is a ROS-responsive fluorogenic prodrug developed by researchers at IIT Guwahati IASST. It is designed to release NBDHEX, an inhibitor of S-transferase pi (GSTP1), when activated by reactive oxygen cocomo-skin-step6-variant:45366437478646
>
glutathione and triple negative breast cancer RK-251 is a ROS-responsive fluorogenic prodrug developed by researchers at IIT Guwahati IASST. It is designed to release NBDHEX, an inhibitor of S-transferase pi (GSTP1), when activated by reactive oxygen cocomo-skin-step6-variant:45366437478646
download picture
description
glutathione and triple negative breast cancer RK-251 is a ROS-responsive fluorogenic prodrug developed by researchers at IIT Guwahati IASST. It is designed to release NBDHEX, an inhibitor of S-transferase pi (GSTP1), when activated by reactive oxygen cocomo-skin-step6-variant:45366437478646
Shopping security
product description
Why choose thelockerguy wholesale?
glutathione and triple negative breast cancer RK-251 is a ROS-responsive fluorogenic prodrug developed by researchers at IIT Guwahati IASST. It is designed to release NBDHEX, an inhibitor of S-transferase pi (GSTP1), when activated by reactive oxygen cocomo-skin-step6-variant:45366437478646
Q Switch Laser Treatment Cost & Side Effects: Price Starts At INR 4,500
Think light gels, milky emulsions, or fast-absorbing fluids instead
cocomo-skin-step6-variant:45366437478646
Choose Kit:Microbiome Restore (with Pre + Postbiotics)
[DOI] [PMC free article] [PubMed] [Google Scholar] 80.Harris C
glutathione and triple negative breast cancer RK-251 is a ROS-responsive fluorogenic prodrug developed by researchers at IIT Guwahati IASST. It is designed to release NBDHEX, an inhibitor of S-transferase pi (GSTP1), when activated by reactive oxygen cocomo-skin-step6-variant:45366437478646
Item no
:
71829234401
US$ 29.01
Pay in 4 interest-free payments of $7.25 Learn more
Min. order:
1piece
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 7 - Oct 12
US$40
Get nowSign up to your membership to get coupons up to
15%
Get nowOpportunity to enjoy order discount up to 15% off
Please add the products
Shipping Notes
- Free Standard Shipping on $100+ Orders to the USA.
- Except Preorder products are shipped in 48 hours.
- Delivery to the USA:
- Standard Shipping : 3-10 business days
- If time is of the essence, please consider selecting expedited delivery for faster service.
Exchange/Return Notes
- We offer a 30-day return/exchange service after receiving.
- Final sale items are not eligible for returns or exchanges.
- To process your return/exchange, please contact us at [email protected]
- Please click here for more details>>> Return & Exchange Policy
Frequently Asked Questions for glutathione and triple negative breast cancer RK-251 is a ROS-responsive fluorogenic prodrug developed by researchers at IIT Guwahati IASST. It is designed to release NBDHEX, an inhibitor of S-transferase pi (GSTP1), when activated by reactive oxygen cocomo-skin-step6-variant:45366437478646
What should I check if an approved refund has not appeared yet?
Ask the seller whether any required step remains incomplete. Confirm the actual recorded outcome against the agreed resolution.
How can I get useful help from the seller about a product or order?
Describe what you expected and what remains unclear. If the stated response period passes, follow the seller's published follow-up route.
How should I interpret words such as up to, from, or optional in an offer?
Look at any explanation placed near the qualified claim. Check whether different versions have different limits or starting values.